{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T22:41:18Z","timestamp":1769640078254,"version":"3.49.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jem-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Emergency Medicine"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.jemermed.2016.11.034","type":"journal-article","created":{"date-parts":[[2017,1,24]],"date-time":"2017-01-24T18:20:30Z","timestamp":1485282030000},"page":"e111-e113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Acute Generalized Erythrodermic Pustular Psoriasis Associated with Bupropion\/Naltrexone (Contrave\u00ae)"],"prefix":"10.1016","volume":"52","author":[{"given":"Priyanka A.","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerry P.","family":"Cassel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald M.","family":"Moscati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Eckersley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jemermed.2016.11.034_bib1","doi-asserted-by":"crossref","first-page":"ii18","DOI":"10.1136\/ard.2004.033217","article-title":"Psoriasis: epidemiology, clinical features, and quality of life","volume":"64","author":"Langley","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jemermed.2016.11.034_bib2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jemermed.2016.11.034_bib3","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jaad.2009.05.048","article-title":"Treatment of erythrodermic psoriasis: from medical board of the National Psoriasis Foundation","volume":"62","author":"Rosenbach","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jemermed.2016.11.034_bib4","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.2146\/ajhp070575","article-title":"Bupropion-induced angioedemia","volume":"65","author":"Tackett","year":"2008","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jemermed.2016.11.034_bib5","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S1081-1206(10)61853-4","article-title":"Drug-induced rash with eosinophilia and systemic symptoms with bupropion administration","volume":"90","author":"Bagshaw","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jemermed.2016.11.034_bib6","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1345\/aph.19297","article-title":"Bupropion-induced serum sickness-like reaction","volume":"34","author":"McCollom","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jemermed.2016.11.034_bib7","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1046\/j.1365-2133.2002.04679.x","article-title":"Generalized pustular and erythrodermic psoriasis associated with bupropion treatment","volume":"146","author":"Cox","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jemermed.2016.11.034_bib8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1684\/ejd.2010.1180","article-title":"Drug eruption and exacerbation of psoriasis related to bupropion","volume":"21","author":"G\u00f3mez-Fern\u00e1ndez","year":"2011","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jemermed.2016.11.034_bib9","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1592\/phco.31.6.621","article-title":"Bupropion-induced acute generalized exanthematous pustulosis","volume":"31","author":"Ray","year":"2011","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jemermed.2016.11.034_bib10","first-page":"32","article-title":"Drug-provoked psoriasis: is it drug induced or drug aggravated?","volume":"3","author":"Kim","year":"2010","journal-title":"J Clin Aesthetic Dermatol"},{"key":"10.1016\/j.jemermed.2016.11.034_bib11","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1001\/jama.2014.732","article-title":"Prevalence of childhood and adult obesity in the United States, 2011\u20132012","volume":"311","author":"Ogden","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jemermed.2016.11.034_bib12","doi-asserted-by":"crossref","first-page":"w822","DOI":"10.1377\/hlthaff.28.5.w822","article-title":"Annual medical spending attributable to obesity: payer and service-specific estimates","volume":"28","author":"Finkelstein","year":"2009","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.jemermed.2016.11.034_bib13","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1210\/jc.2014-3415","article-title":"Pharmacological management of obesity: an Endocrine Society Clinical Practice Guideline","volume":"100","author":"Aprovian","year":"2015","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073646791631071X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073646791631071X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:38:18Z","timestamp":1760027898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073646791631071X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S073646791631071X"],"URL":"https:\/\/doi.org\/10.1016\/j.jemermed.2016.11.034","relation":{},"ISSN":["0736-4679"],"issn-type":[{"value":"0736-4679","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute Generalized Erythrodermic Pustular Psoriasis Associated with Bupropion\/Naltrexone (Contrave\u00ae)","name":"articletitle","label":"Article Title"},{"value":"The Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jemermed.2016.11.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}